Natural History and Treatment of Bone Complications in Prostate Cancer
- 31 March 2006
- journal article
- review article
- Published by Elsevier in European Urology
- Vol. 49 (3) , 429-440
- https://doi.org/10.1016/j.eururo.2005.12.045
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Bone Turnover Markers as Predictors of Skeletal Complications in Prostate Cancer, Lung Cancer, and Other Solid TumorsJNCI Journal of the National Cancer Institute, 2005
- Osteoblasts in prostate cancer metastasis to boneNature Reviews Cancer, 2005
- Role of Bisphosphonates in Prostate CancerEuropean Urology, 2004
- General Principles of External Beam Radiation Therapy for Skeletal MetastasesClinical Orthopaedics and Related Research, 2003
- Endothelin receptor antagonists in the treatment of prostate cancerSeminars in Oncology, 2003
- Randomized, Double-Blind, Controlled Trial of Mitoxantrone/Prednisone and Clodronate Versus Mitoxantrone/Prednisone and Placebo in Patients With Hormone-Refractory Prostate Cancer and PainJournal of Clinical Oncology, 2003
- Diagnosis and management of treatment-related osteoporosis in men with prostate carcinomaCancer, 2003
- Parathyroid hormone-related peptide: expression in prostate cancer bone metastasesProstate Cancer and Prostatic Diseases, 2002
- INCIDENCE OF SKELETAL COMPLICATIONS IN PATIENTS WITH BONE METASTATIC PROSTATE CANCER AND HORMONE REFRACTORY DISEASE: PREDICTIVE ROLE OF BONE RESORPTION AND FORMATION MARKERS EVALUATED AT BASELINEJournal of Urology, 2000
- Osteomimetic properties of prostate cancer cells: A hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environmentThe Prostate, 1999